Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Blood|January 10, 2025
Donor regulatory T-cell therapy to prevent graft-versus-host diseaseEverett H Meyer, Anna Pavlova, Alejandro Villar-Prados, et al.
The New England Journal of Medicine|October 19, 2012
Peripheral-blood stem cells versus bone marrow from unrelated donorsClaudio Anasetti, Brent R Logan, Stephanie J Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 3, 2018
ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant SurvivorsShahrukh K Hashmi, Stephanie J Lee, Bipin N Savani, et al.
Blood|July 5, 2024
A phase 1 clinical trial of NKTR-255 with CD19-22 CAR T-cell therapy for refractory B-cell acute lymphoblastic leukemiaHrishikesh Srinagesh, Clayton Jackson, Parveen Shiraz, et al.
Blood|January 29, 2021
CD22-directed CAR T-cell therapy induces complete remissions in CD19-directed CAR-refractory large B-cell lymphomaJohn H Baird, Matthew J Frank, Juliana Craig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 18, 2017
Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell TransplantationRobert J Soiffer, Haesook T Kim, Joseph McGuirk, et al.
Blood Advances|November 21, 2025
CHARM is Prognostic of Geriatric Morbidity and Toxicity after Allogeneic Transplant for Older Adults: BMT CTN 1704 StudyAndrew S Artz, Brent R Logan, Wael Saber, et al.
Research Square|November 24, 2025
CAR19 therapy drives expansion of clonal hematopoiesis and associated cytopeniasMark P Hamilton, Nick Phillips, Troy Noordenbos, et al.
Bone Marrow Transplantation|May 17, 2019
Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)-an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT)Ankit J Kansagra, Noelle V Frey, Merav Bar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 22, 2018
Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Blood and Marrow TransplantationAnkit J Kansagra, Noelle V Frey, Merav Bar, et al.
Pageof 9